DEF 14A: Nauticus Robotics Seeks Stockholder Approval for Key Share Issuance Proposals

Nauticus Robotics is holding a special meeting to seek stockholder approval for the issuance of common stock related to convertible preferred stock and debentures.

Summary

• Nauticus Robotics is seeking stockholder approval for three proposals at a special meeting on December 18, 2024.
• The first proposal involves approving the issuance of common stock upon conversion of Series A Convertible Preferred Stock issued under an agreement dated November 4, 2024.
• The second proposal seeks approval for the issuance of common stock upon conversion of debt under senior secured convertible debentures also issued on November 4, 2024.
• The third proposal is to allow for adjournment of the special meeting if necessary to solicit additional proxies.
• These proposals are required under Nasdaq rules due to the potential for significant issuances of common stock at prices below the minimum price.
• The company is seeking approval to issue up to 32 million shares of common stock upon conversion of the Series A Preferred Stock and up to 20.6 million shares upon conversion of the debentures.
• The company needs these approvals to maintain its listing on the Nasdaq Capital Market.

Sentiment

Score: 4

Explanation: The document is primarily factual and informative, but the underlying situation of the company facing potential delisting and significant dilution is concerning. The sentiment is therefore slightly negative.

Positives

• The exchange of debt for preferred stock will increase the company's stockholders equity.
• The capital obtained from the debentures will be used for general corporate purposes.
• The company has been granted an exception until December 31, 2024, to demonstrate compliance with Nasdaq listing rules.

Negatives

• The issuance of common stock upon conversion of the preferred stock and debentures will cause substantial dilution to existing stockholders.
• The conversion price of the preferred stock and debentures can be adjusted downwards, potentially leading to the issuance of more shares.
• If the company does not receive approval for these proposals, it may be delisted from the Nasdaq Capital Market.
• The company may be required to hold additional stockholder meetings if these proposals are not approved.

Risks

• The issuance of common stock will cause substantial dilution, which may materially affect the trading price of the common stock and earnings per share.
• If the company defaults on any terms or obligations relating to the Series A Preferred Stock, the company's financial condition, results of operations, liquidity, prospects, and cash flows would be materially and adversely impacted.
• If the company does not receive approval for these proposals, it may be delisted from the Nasdaq Capital Market.
• The company may be unable to obtain alternative financing if these proposals are not approved.

Future Outlook

The company is seeking stockholder approval to fully issue all shares of common stock that are issuable pursuant to the Exchange Agreement and the Securities Purchase Agreement, if necessary, under the terms of those agreements. The company is also seeking to maintain its listing on the Nasdaq Capital Market.

Management Comments

• Our Board of Directors unanimously recommends that you vote FOR each of the proposals described in this Proxy Statement.
• Our Board has determined that the Exchange Agreement, and the Common Stock that may be issued thereby, are in the best interests of the Company and its stockholders because of the corresponding increase in the stockholders equity in the Company that will result from the exchange of the New Debentures for the Series A Preferred Stock, and the contribution of that additional stockholders equity toward gaining compliance with the Equity Rule before December 31, 2024.
• Our Board has determined that the SPA, the November 2024 Debentures, and the Common Stock that may be issued thereby, are in the best interests of the Company and its stockholders because of the corresponding capital obtained by the Company, and the potential additional capital that may be obtained by the Company in the future under the terms of the SPA.

Industry Context

This announcement is related to the company's efforts to maintain its listing on the Nasdaq Capital Market and secure additional capital. The company is facing challenges related to its stock price and market capitalization, which are common issues for companies in the early stages of development.

Comparison to Industry Standards

• The use of convertible preferred stock and debentures is a common financing method for companies seeking capital, particularly those that are not yet profitable or have volatile stock prices.
• The company's need to seek stockholder approval for these issuances is standard practice under Nasdaq rules.
• The potential for significant dilution is a common risk associated with these types of financing arrangements.
• The company's efforts to regain compliance with Nasdaq listing rules are similar to those of other companies facing similar challenges.

Stakeholder Impact

• Existing stockholders will experience significant dilution of their ownership interests.
• The company's employees may be affected by the company's financial situation and potential delisting.
• The company's creditors may be affected by the company's financial situation and potential delisting.
• The company's customers and suppliers may be affected by the company's financial situation and potential delisting.

Next Steps

• Stockholders will vote on the proposals at the special meeting on December 18, 2024.
• The company will need to demonstrate compliance with Nasdaq listing rules by December 31, 2024.
• The company may need to hold additional stockholder meetings if the proposals are not approved.

Key Dates

Keywords

stockholder approval, common stock, convertible preferred stock, convertible debentures, Nasdaq listing rules, share issuance, dilution, special meeting, capital raise, reverse stock split